Skip to main content
Premium Trial:

Request an Annual Quote

Kirell Lakhman, Joseph Radigan, Martin Klimek


When Kirell Lakhman came on board as the editor of last summer, the visitors to our site were logging about 675,000 page views per month. Thanks to the prolific and high-quality reporting of the K-team — Kirell with reporters Kat McGowan and Ken Howard — GenomeWeb celebrated a new milestone in March: 1 million page views. And still Kirell found time to turn out two interesting little stories for this issue of GT: “Extreme Extraction: Portable Igloos, Chilly Genomics Studies,” p. 28; and “Hotly Debated Legislation Would Open IP to Academics,” p. 30.

Joseph Radigan is a business journalist who has been writing about finance and high-technology since 1986. His background includes two years as an editor with Waters Information Services and five years at US Banker. He lives near New York City with his wife Kathy, son Tom, and daughter Elizabeth, who was born while Joe was writing “Data Crisis Overblown, Say Those Who Deal with Data,” p. 34.

Martin Klimek is a San Francisco-based freelance photographer covering the science and business of Silicon Valley and environs. He shot both the pharmacogenomics roundtable and photos at Surromed for the nanotechnology feature in this issue. His work has appeared in Business Week, Fortune Small Business, Popular Science, and USA Today.


The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.